Search results
Added:
1 week ago
HRS 25 - First-in-human study demonstrates successful implantation of a novel leadless pacemaker with clinically acceptable intraprocedural electrical performance and safety.We are joined by Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, New York, US) to discuss the findings from a feasibility study investigating the safety and performance of a novel helix-based leadless pacemaker with…
View more
Added:
1 week ago
HRS 2025 - First-in-human three-month results from a contact force-sensing catheter integrated with 3D mapping to treat paroxysmal atrial fibrillation (PAF) show potential for high acute effectiveness and a promising safety profile.Dr Mattias Duytschaever (St Jan Hospital, Bruges, BE) joins us to discuss the three-month findings from the first-in-human Omny-IRE study (NCT05971693; Biosense…
View more
Added:
1 month ago
EHRA 2025 - Follow-up outcomes of a balloon-in-basket pulsed field ablation (PFA) system for pulmonary vein isolation (PVI) show high acute PVI isolation rates and a low adverse event rate. Overall, the balloon-in-basket PFA system proved to be a safe and feasible treatment option for PVI.Prof Roland Tilz (University Heart Centre Lübeck, Lübeck, Germany) joins us on-site at EHRA Congress 2025 to…
View more
Added:
8 months ago
ESC Congress 24 — SHAM-PVI study finds pulmonary vein isolation effective in reducing atrial fibrillation (AF) episodes, improving quality of life.We are joined onsite by Dr Rick Veasey (Eastbourne District General Hospital, Eastbourne, UK) to discuss the findings from a SHAM-PVI, a randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation (NCT04272762; East…
View more
Added:
1 year ago
ACC.24 — We are joined by Dr Kengo Kusano (National Cerebral and Cardiovascular Center, JP) to discuss the findings from the Embo-Abl Study.Embo-Abl is a multicenter prospective randomized study which aims to compare the incidence of periprocedural cerebral embolisms caused by catheter ablation of atrial fibrillation (AF) between cryoballoon and radiofrequency ablation. 230 patients with AF from…
View more
Added:
11 months ago
HRS 24 - Dr Larry Chinitz (NYU School of Medicine, US) joins us to discuss the findings of the prospective, multicenter BIO-CONDUCT study, which investigated the safety and efficacy of the BIOTRONIK Solia S pacing lead implanted in the left bundle branch area (LBB) (NCT05251363, Biotronik Inc.). 186 patients with atrioventricular block, bradycardia, left bundle-branch block or cardiomyopathies…
View more
Added:
1 year ago
AF Symposium 2024 — Professor Angelo Auricchio (Fondazione Cardiocentro Ticino, CH), Editor-in-Chief of EP Europace and Arrhythmia Academy, has joined us to share the highlights from the latest data presented first at the AF Symposium.In this brief summary, Professor Auricchio outlines the findings from the following studies:Acute Kidney Injury Resulting From Hemoglobinuria Following Pulsed-Field…
View more
Start date:
Oct 16, 2024
This one-hour virtual program will feature presentations and interactive discussion focused on the recently presented data on PulseSelect PFA system and new clinical research on durability with PFA. We will also discuss efficiency workflow tips and a multi-user center’s real-world experience.UC202503229 EN
View more
Added:
2 months ago
Added:
1 week ago
HRS 2025 - Contemporary outcomes from implantable devices in non-ischemic cardiomyopathy patients observed more advanced heart failure symptoms in women at the time of ICD implantation, and white women implanted with CRT-D devices had significantly lower ventricular arrhythmia events compared to men of all races and black women implanted with both device types.Dr Valentina Kutyifa (University of…
View more
